Global Infertility Diagnostics Devices Market Report and Forecast 2024-2032

Global Infertility Diagnostics Devices Market Outlook

The global infertility diagnostics devices market size is expected to grow at a CAGR of 8.80% during the forecast period of 2024-2032, driven by increasing prevalence of infertility along with technical advancements across the globe.

Key Takeaways

• Recently WHO estimated that nearly 17.5% of the adult population which makes around 1 in 6 individuals worldwide experience infertility in their lifetime. This estimation creates a sense of urgent, affordable, and high-quality fertility care for those in need.

• In Feb 2024, Australian researchers found that an ultrasound technique may provide a new way to boost sperm movement in the lab, stating that non-invasive technique can increase human sperm movement in the laboratory by 266%. 

• The heightened research activities to develop cutting-edge infertility diagnostic tools among both male and female individuals are projected to augment infertility diagnostics devices market demand.

Infertility is an issue that people are facing worldwide. Currently, 1 in every 6 adults suffers from infertility globally. Some major causes for this condition include, a sedentary lifestyle, tobacco, and alcohol consumption, genetics, and environmental factors, among others. Infertility can be diagnosed by undergoing several procedures that require a range of equipment and tools. It has been predicted that persisting conditions may contribute greatly to the decline in male and female fertility by 2060.

Global Infertility Diagnostics Devices Market Trends and Developments

Rising awareness, advancements in diagnostic equipment, and increasing demand for non-invasive diagnosing procedures for infertility comprise some of the key trends and developments in the market.

Global Infertility Diagnostics Devices Market Analysis

The market growth can be attributed to the increasing rates of infertility along with rising advancements in diagnostic tools. The increasing shift toward single parenting and same-sex couples wanting to conceive is fuelling the market. The increasing awareness and people coming out of their comfort zones to get diagnosed with infertility issues further boost the market.

Global Infertility Diagnostics Devices Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

By product type, the infertility diagnostics devices market share is divided into imaging systems ultrasounds, ovulation prediction kits, sperm analysis systems, and others. Additionally, imaging systems ultrasounds are segmented into ultrasound, and MRI Systems, among others.

The market is segmented by test types into female infertility testing and male infertility testing. Female testing includes ovarian reserve testing, hormonal level testing, tubal patency testing, and others. Further, male infertility testing is divided into semen analysis, DNA fragmentation, and other sperm function tests.

The patient type segment encompasses both male and female patients. With rising lifestyle changes, male and female individuals experience fertility issues parallelly.

By end users, the infertility diagnostics devices market segmentation constitutes hospitals, fertility clinics, homecare settings, and others. Infertility diagnostic tools are used for several testing and treatment procedures at hospitals, and fertility clinics, among other sites.

Based on region, the market report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market is driven by technological advancements, and rising awareness among people. However, the level of market development and growth rates may vary from region to region.

Global Infertility Diagnostics Devices Market: Competitive Landscape
 

The key market players contributing to market growth through strategic mergers and acquisitions initiatives, novel product launches, and continuous research and development efforts are as follows:

Other key players in the market include ARQUIMEA, Intin Inc., Hamilton Thorne, Medical Electronic Systems, Bioteknika Healthcare Pvt. Ltd., Varay Laborix, Agappe Diagnostic’s Ltd., Atlas Medical GmbH, Advy Chemical Pvt. Ltd, Trajan Scientific and Medical, Getein Biotech, Inc., and Beckman Coulter, Inc., among others.

Global Infertility Diagnostics Devices Market Analysis by Region

North America is the leading regional market, owing to the presence of key players, the advanced healthcare system which is experiencing rapid advancements, and the higher diagnosis rates of infertility testing. Moreover, the rising rates of infertility and research activities in the region are expected to fuel the infertility diagnostics devices market size in the forecast period.

Europe is the following region in the market. The growth can be attributed to the supportive government policies, high public and private healthcare expenditure, and availability of cutting-edge treatments for the condition. Asia Pacific is expected to witness rapid growth in the coming years, owing to increased government initiatives around spreading knowledge around infertility. Rising disposable incomes also fuel the market value in the region.

Key Highlights of the Report